期刊中(zhong)文名:內分泌(mi)ISSN:1355-008XE-ISSN:1559-0100
該(gai)雜志(zhi)國(guo)際簡稱:ENDOCRINE,是由出版(ban)商(shang)Springer US出版(ban)的(de)(de)(de)一(yi)本(ben)(ben)致力于(yu)發布醫學研究新(xin)(xin)成(cheng)果(guo)(guo)的(de)(de)(de)的(de)(de)(de)專(zhuan)業學術(shu)期刊(kan)。該(gai)雜志(zhi)以ENDOCRINOLOGY & METABOLISM研究為(wei)重點,主要發表(biao)刊(kan)登有創見的(de)(de)(de)學術(shu)論(lun)文文章、行業最新(xin)(xin)科研成(cheng)果(guo)(guo),扼(e)要報道階(jie)段性研究成(cheng)果(guo)(guo)和(he)重要研究工(gong)作的(de)(de)(de)最新(xin)(xin)進展(zhan),選載對學科發展(zhan)起指導作用的(de)(de)(de)綜述與專(zhuan)論(lun),促進學術(shu)發展(zhan),為(wei)廣大讀者服務。該(gai)刊(kan)是一(yi)本(ben)(ben)國(guo)際優(you)秀雜志(zhi),在(zai)國(guo)際上有很(hen)高的(de)(de)(de)學術(shu)影(ying)響力。
《Endocrine》是一本(ben)以English為(wei)主的未開放獲取國際優秀期刊(kan)(kan),中(zhong)文名稱內分(fen)泌,本(ben)刊(kan)(kan)主要出(chu)版、報道(dao)醫學-ENDOCRINOLOGY & METABOLISM領域(yu)(yu)的研究動態以及在(zai)該(gai)領域(yu)(yu)取得的各方(fang)(fang)面的經驗(yan)和科(ke)研成果,介紹該(gai)領域(yu)(yu)有(you)關(guan)(guan)本(ben)專業(ye)(ye)的最新進展(zhan),探討行業(ye)(ye)發(fa)(fa)展(zhan)的思路和方(fang)(fang)法,以促進學術信息交流,提高行業(ye)(ye)發(fa)(fa)展(zhan)。該(gai)刊(kan)(kan)已被(bei)國際權威(wei)數據庫SCIE收錄,為(wei)該(gai)領域(yu)(yu)相關(guan)(guan)學科(ke)的發(fa)(fa)展(zhan)起到(dao)了(le)良好的推動作用,也得到(dao)了(le)本(ben)專業(ye)(ye)人員的廣泛(fan)認可。該(gai)刊(kan)(kan)最新影(ying)響(xiang)因子為(wei)3,最新CiteScore 指(zhi)數為(wei)6.5。
本刊近期中國學(xue)者發表(biao)的論文主要有:
Author: Cai, Yunying; Su, Heng; Si, Yongting; Ni, Ninghua
Author: Wang, Shiwei; Wang, Yu; Zhu, Li; He, Liang; Lv, Mutian; Zhang, Hao; Wang, Haoyu; Zhang, Fan; Lai, Yaxin; Li, Yushu; Shan, Zhongyan; Teng, Weiping
Author: Li, Liangshan; Li, Xiaole; Wang, Xiaoyu; Han, Mengmeng; Zhao, Dehua; Wang, Fang; Liu, Shiguo
Author: Parameswaran, Rajeev; de Jong, Mechteld Christine; Kit, James Lee Wai; Sek, Kathleen; Tran Quang Nam; Tran Viet Thang; Nguyen Thy Khue; Than Than Aye; Phone Myint Tun; Cole, Timothy; Miller, Julie A.; Villa, Michael; Khiewvan, Benjapa; Sirinvaravong, Sirinart; Sin, Yong Lit; Muhammad, Rohaizak; Jap, Tjin Shing; Agrawal, Amit; Rajput, Rajesh; Fernando, Ranil; Sumanatilleke, Manilka; Suastika, Ketut; Shong, Young Kee; Lang, Brian; Bartalena, Luigi; Yang, Samantha Peiling
Well-established as a major journal in today’s rapidly advancing experimental and clinical research areas, Endocrine publishes original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority, and editorial decision. Invited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics, as well as Editorials on articles appearing in the Journal, are published. Unsolicited Editorials will be evaluated by the editorial team. Outcomes of scientific meetings, as well as guidelines and position statements, may be submitted. The Journal also considers special feature articles in the field of endocrine genetics and epigenetics, as well as articles devoted to novel methods and techniques in endocrinology.
Endocrine covers controversial, clinical endocrine issues. Meta-analyses on endocrine and metabolic topics are also accepted. Descriptions of single clinical cases and/or small patients studies are not published unless of exceptional interest. However, reports of novel imaging studies and endocrine side effects in single patients may be considered. Research letters and letters to the editor related or unrelated to recently published articles can be submitted.
Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, adrenal diseases pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology.
2023年12月升級版 |
綜述:否
TOP期刊:否
大類:醫學 3區
小類:
ENDOCRINOLOGY & METABOLISM |
2022年12月(yue)升級版 |
綜述:否
TOP期刊:否
大類:醫學 3區
小類:
ENDOCRINOLOGY & METABOLISM |
2021年(nian)12月舊的(de)升級版 |
綜述:否
TOP期刊:否
大類:醫學 3區
小類:
ENDOCRINOLOGY & METABOLISM |
2021年12月基礎版 |
綜述:否
TOP期刊:否
大類:醫學 3區
小類:
ENDOCRINOLOGY & METABOLISM |
2021年12月升級版 |
綜述:否
TOP期刊:否
大類:醫學 3區
小類:
ENDOCRINOLOGY & METABOLISM |
2020年12月舊的升級版 |
綜述:否
TOP期刊:否
大類:醫學 2區
小類:
ENDOCRINOLOGY & METABOLISM |
中科院SCI分區:是中國科(ke)(ke)(ke)學院(yuan)文(wen)獻情報中心(xin)科(ke)(ke)(ke)學計量中心(xin)的(de)科(ke)(ke)(ke)學研究成果。期刊(kan)(kan)分區(qu)(qu)表(biao)自2004年(nian)開始發布(bu),延續至今(jin);2019年(nian)推出升(sheng)(sheng)級版,實現(xian)基礎版、升(sheng)(sheng)級版并存過渡,2022年(nian)只發布(bu)升(sheng)(sheng)級版,期刊(kan)(kan)分區(qu)(qu)表(biao)數據每年(nian)底發布(bu)。 中科(ke)(ke)(ke)院(yuan)分區(qu)(qu)為(wei)(wei)4個區(qu)(qu)。中科(ke)(ke)(ke)院(yuan)分區(qu)(qu)采(cai)用(yong)刊(kan)(kan)物(wu)前(qian)3年(nian)影響因(yin)子平均(jun)值進(jin)行分區(qu)(qu),即(ji)前(qian)5%為(wei)(wei)該類1區(qu)(qu),6%~20%為(wei)(wei)2區(qu)(qu)、21%~50%為(wei)(wei)3區(qu)(qu),其(qi)余的(de)為(wei)(wei)4區(qu)(qu)。1區(qu)(qu)和2區(qu)(qu)雜志(zhi)很少,雜志(zhi)質量相對(dui)也高,基本都是本領域的(de)頂(ding)級期刊(kan)(kan)。
按JIF指標學(xue)科分區 |
學科:ENDOCRINOLOGY & METABOLISM
收錄子集:SCIE
分區:Q2
排名:88 / 186
百分位:
53% |
按JCI指(zhi)標學科分區 |
學科:ENDOCRINOLOGY & METABOLISM
收錄子集:SCIE
分區:Q2
排名:91 / 186
百分位:
51.34% |
JCR分區:JCR分區來自科(ke)睿唯安公(gong)司,JCR是一(yi)(yi)個(ge)獨特的(de)(de)(de)多學科(ke)期(qi)刊評(ping)價(jia)工具,為(wei)(wei)唯一(yi)(yi)提供基(ji)于引(yin)文數據(ju)的(de)(de)(de)統計(ji)信息的(de)(de)(de)期(qi)刊評(ping)價(jia)資源。每年(nian)發布的(de)(de)(de)JCR分區,設置了254個(ge)具體學科(ke)。JCR分區根據(ju)每個(ge)學科(ke)分類按照(zhao)期(qi)刊當年(nian)的(de)(de)(de)影響(xiang)因子高(gao)低(di)將期(qi)刊平均分為(wei)(wei)4個(ge)區,分別為(wei)(wei)Q1、Q2、Q3和(he)Q4,各(ge)占25%。JCR分區中期(qi)刊的(de)(de)(de)數量是均勻分為(wei)(wei)四個(ge)部分的(de)(de)(de)。
學科類別 | 分區 | 排名 | 百分位 |
大類:Medicine 小類:Endocrinology, Diabetes and Metabolism | Q2 | 79 / 244 |
67% |
大類:Medicine 小類:Endocrinology | Q2 | 48 / 128 |
62% |
該(gai)(gai)雜(za)(za)(za)志是一(yi)(yi)本國際優秀雜(za)(za)(za)志,在國際上(shang)有較高(gao)的學術影響力(li),行(xing)業關(guan)注度很高(gao),已被國際權威數據庫SCIE收錄,該(gai)(gai)雜(za)(za)(za)志在ENDOCRINOLOGY & METABOLISM綜合專業領(ling)域(yu)專業度認可很高(gao),對稿(gao)(gao)件內容的創(chuang)新性(xing)和學術性(xing)要求很高(gao),作為一(yi)(yi)本國際優秀雜(za)(za)(za)志,一(yi)(yi)般投(tou)(tou)(tou)稿(gao)(gao)過審時(shi)(shi)間(jian)都(dou)較長,投(tou)(tou)(tou)稿(gao)(gao)過審時(shi)(shi)間(jian)平均 約1.5月(yue) ,如果想(xiang)(xiang)投(tou)(tou)(tou)稿(gao)(gao)該(gai)(gai)刊要做好時(shi)(shi)間(jian)安排。版面費不祥。該(gai)(gai)雜(za)(za)(za)志近兩(liang)年未被列入預警名(ming)單,建議(yi)您投(tou)(tou)(tou)稿(gao)(gao)。如您想(xiang)(xiang)了解更(geng)多投(tou)(tou)(tou)稿(gao)(gao)政策(ce)及投(tou)(tou)(tou)稿(gao)(gao)方案,請咨詢客服。
若用(yong)戶(hu)需要出(chu)版服務,請(qing)聯系出(chu)版商:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United States, NY, 10004。
RESPIRATORY SYSTEM
中科院 3區
INTEGRATIVE & COMPLEMENTARY MEDICINE
中科院 2區
ONCOLOGY
中科院 2區
DENTISTRY, ORAL SURGERY & MEDICINE
中科院 2區
GASTROENTEROLOGY & HEPATOLOGY
中科院 4區
HEALTH CARE SCIENCES & SERVICES
中科院 4區
PHARMACOLOGY & PHARMACY
中科院 2區
HEALTH CARE SCIENCES & SERVICES
中科院 3區